452 related articles for article (PubMed ID: 9008467)
21. Initiation of mineralization in bioprosthetic heart valves: studies of alkaline phosphatase activity and its inhibition by AlCl3 or FeCl3 preincubations.
Levy RJ; Schoen FJ; Flowers WB; Staelin ST
J Biomed Mater Res; 1991 Aug; 25(8):905-35. PubMed ID: 1918108
[TBL] [Abstract][Full Text] [Related]
22. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model.
Weissenstein C; Human P; Bezuidenhout D; Zilla P
J Heart Valve Dis; 2000 Mar; 9(2):230-40. PubMed ID: 10772041
[TBL] [Abstract][Full Text] [Related]
23. Amide cross-linking: an alternative to glutaraldehyde fixation.
Girardot JM; Girardot MN
J Heart Valve Dis; 1996 Sep; 5(5):518-25. PubMed ID: 8894992
[TBL] [Abstract][Full Text] [Related]
24. Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential.
Pathak CP; Adams AK; Simpson T; Phillips RE; Moore MA
J Biomed Mater Res A; 2004 Apr; 69(1):140-4. PubMed ID: 14999761
[TBL] [Abstract][Full Text] [Related]
25. Prevention of tissue calcification on bioprosthetic heart valve by using epoxy compounds: a study of calcification tests in vitro and in vivo.
Xi T; Ma J; Tian W; Lei X; Long S; Xi B
J Biomed Mater Res; 1992 Sep; 26(9):1241-51. PubMed ID: 1429769
[TBL] [Abstract][Full Text] [Related]
26. Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms.
Connolly JM; Alferiev I; Clark-Gruel JN; Eidelman N; Sacks M; Palmatory E; Kronsteiner A; Defelice S; Xu J; Ohri R; Narula N; Vyavahare N; Levy RJ
Am J Pathol; 2005 Jan; 166(1):1-13. PubMed ID: 15631995
[TBL] [Abstract][Full Text] [Related]
27. Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization.
Schoen FJ; Tsao JW; Levy RJ
Am J Pathol; 1986 Apr; 123(1):134-45. PubMed ID: 2421577
[TBL] [Abstract][Full Text] [Related]
28. Prevention of calcification of glutaraldehyde pretreated bovine pericardium through controlled release polymeric implants: studies of Fe3+, Al3+, protamine sulphate and levamisole.
Pathak YV; Boyd J; Levy RJ; Schoen FJ
Biomaterials; 1990 Nov; 11(9):718-23. PubMed ID: 2128616
[TBL] [Abstract][Full Text] [Related]
29. Covalent binding of aminopropanehydroxydiphosphonate to glutaraldehyde residues in pericardial bioprosthetic tissue: stability and calcification inhibition studies.
Webb CL; Schoen FJ; Levy RJ
Exp Mol Pathol; 1989 Jun; 50(3):291-302. PubMed ID: 2498121
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups.
Webb CL; Benedict JJ; Schoen FJ; Linden JA; Levy RJ
Ann Thorac Surg; 1988 Sep; 46(3):309-16. PubMed ID: 3137904
[TBL] [Abstract][Full Text] [Related]
31. Calcium mitigation in bioprosthetic tissues by iron pretreatment: the challenge of iron leaching.
Carpentier SM; Carpentier AF; Chen L; Shen M; Quintero LJ; Witzel TH
Ann Thorac Surg; 1995 Aug; 60(2 Suppl):S332-8. PubMed ID: 7646183
[TBL] [Abstract][Full Text] [Related]
32. Effects of fixation back pressure and antimineralization treatment on the morphology of porcine aortic bioprosthetic valves.
Flomenbaum MA; Schoen FJ
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):154-64. PubMed ID: 8419696
[TBL] [Abstract][Full Text] [Related]
33. Heat treatment mitigates calcification of valvular bioprostheses.
Carpentier SM; Chen L; Shen M; Fornes P; Martinet B; Quintero LJ; Witzel TH; Carpentier AF
Ann Thorac Surg; 1998 Dec; 66(6 Suppl):S264-6. PubMed ID: 9930461
[TBL] [Abstract][Full Text] [Related]
34. No-react detoxification process: a superior anticalcification method for bioprostheses.
Abolhoda A; Yu S; Oyarzun JR; Allen KR; McCormick JR; Han S; Kemp FW; Bogden JD; Lu Q; Gabbay S
Ann Thorac Surg; 1996 Dec; 62(6):1724-30. PubMed ID: 8957377
[TBL] [Abstract][Full Text] [Related]
35. Calcification resistance of procyanidin-treated decellularized porcine aortic valves in vivo.
Liu Y; Liu W; Sun G; Wei X; Yi D
Heart Surg Forum; 2009 Jan; 12(1):E24-9. PubMed ID: 19233761
[TBL] [Abstract][Full Text] [Related]
36. Role of elastin in pathologic calcification of xenograft heart valves.
Bailey MT; Pillarisetti S; Xiao H; Vyavahare NR
J Biomed Mater Res A; 2003 Jul; 66(1):93-102. PubMed ID: 12833435
[TBL] [Abstract][Full Text] [Related]
37. Neomycin and carbodiimide crosslinking as an alternative to glutaraldehyde for enhanced durability of bioprosthetic heart valves.
Leong J; Munnelly A; Liberio B; Cochrane L; Vyavahare N
J Biomater Appl; 2013 May; 27(8):948-60. PubMed ID: 22207605
[TBL] [Abstract][Full Text] [Related]
38. Refinement of the alpha aminooleic acid bioprosthetic valve anticalcification technique.
Gott JP; Girardot MN; Girardot JM; Hall JD; Whitlark JD; Horsley WS; Dorsey LM; Levy RJ; Chen W; Schoen FJ; Guyton RA
Ann Thorac Surg; 1997 Jul; 64(1):50-8. PubMed ID: 9236334
[TBL] [Abstract][Full Text] [Related]
39. A universal strategy for the construction of polymer brush hybrid non-glutaraldehyde heart valves with robust anti-biological contamination performance and improved endothelialization potential.
Yu T; Zheng C; Chen X; Pu H; Li G; Jiang Q; Wang Y; Guo Y
Acta Biomater; 2023 Apr; 160():87-97. PubMed ID: 36812953
[TBL] [Abstract][Full Text] [Related]
40. Inhibition by diphosphonate compounds of calcification of porcine bioprosthetic heart valve cusps implanted subcutaneously in rats.
Levy RJ; Hawley MA; Schoen FJ; Lund SA; Liu PY
Circulation; 1985 Feb; 71(2):349-56. PubMed ID: 3917378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
